Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00222
|
|||||
| EM Name |
Trihydroxycoprostane
|
|||||
| Synonyms |
Trihydroxycoprostane; 5beta-Cholestane-3alpha,7alpha,12alpha-triol; 3,7,12-Trihydroxycholestane; 5-b-Cholestane-3a ,7a ,12a-triol; (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol; 3alpha,7alpha,12alpha-Trihydroxycoprostane; trihydroxycholestane; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane; 3,7,12-Trihydroxycoprostane; (3; A,5; A,7; A,12; A)-cholestane-3,7,12-triol; AC1L4NRJ
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=160520"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C27H48O3
|
|||||
| Canonical SMILES |
CC(C)CCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
|
|||||
| InChI |
InChI=1S/C27H48O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h16-25,28-30H,6-15H2,1-5H3/t17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1
|
|||||
| InChIKey |
RIVQQZVHIVNQFH-XJZYBRFWSA-N
|
|||||
| CAS Number |
CAS 547-96-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 420.7 | Topological Polar Surface Area | 60.7 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:16496
|
|||||
| DT(s) "handling" This EM | ABCD1 | Transporter Info | Adrenoleukodystrophy protein | [1] | ||
| References | ||||||
| 1 | Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy. Hum Mol Genet. 2015 Dec 15;24(24):6861-76. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.